Oxygenta Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 37.50 Cr
as on 16-11-2024
- Paid Up Capital ₹ 36.98 Cr
as on 16-11-2024
- Company Age 34 Year, 23 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 53.20 Cr
as on 16-11-2024
- Satisfied Charges ₹ 2.50 Cr
as on 16-11-2024
- Revenue -48.78%
(FY 2023)
- Profit -1795.44%
(FY 2023)
- Ebitda -582.17%
(FY 2023)
- Net Worth -33.41%
(FY 2023)
- Total Assets 74.06%
(FY 2023)
About Oxygenta Pharmaceutical
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 524636.
The Corporate was formerly known as S.S. Organics Pvt Ltd. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 37.50 Cr and a paid-up capital of Rs 36.98 Cr.
The company currently has active open charges totaling ₹53.20 Cr. The company has closed loans amounting to ₹2.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Oxygenta Pharmaceutical Limited India are V Sudhakar as CFO and Dolly Mandhan as Company Secretary. Vankineni Sudhakar, Sunil Chawda, Sanagari Reddy, and Five other members serve as directors at the Company.
- CIN/LLPIN
L24110TG1990PLC012038
- Company No.
012038
- Stock Symbol
BSE : 524636
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
27 Nov 1990
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Hyderabad
Industry
Company Details
- LocationMedak, Telangana
- Telephone
- Email Address
- Website
- Social Media
What products or services does Oxygenta Pharmaceutical Limited offer?
Oxygenta Pharmaceutical Limited offers a wide range of products and services, including Product Development Research, Contract Research Services, Digestive System Drugs & Medicines, Gastrointestinal Drugs, Pharmaceutical Medicine, Pharmaceutical Drug.
Who are the key members and board of directors at Oxygenta Pharmaceutical?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vankineni Sudhakar  | Managing Director | 20-Oct-2006 | Current |
| V Sudhakar | CFO | 31-Mar-2015 | Current |
| Dolly Mandhan | Company Secretary | 01-Oct-2023 | Current |
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Padmaja Surapureddy | Director | 05-Mar-2019 | Current |
| Sunil Chawda | Director | 04-Sep-2023 | Current |
| Sanagari Reddy | Director | 14-Feb-2019 | Current |
| Raghavender Kanuganti | Director | 10-Sep-2020 | Current |
| Aakanksha | Director | 25-Oct-2024 | Current |
| Sravani Gantla | Director | 04-Sep-2023 | Current |
Financial Performance and Corporate Structure Insights of Oxygenta Pharmaceutical.
Oxygenta Pharmaceutical Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 48.78% decrease. The company also saw a substantial fall in profitability, with a 1795.44% decrease in profit. The company's net worth observed a substantial decline by a decrease of 33.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Oxygenta Pharmaceutical?
In 2023, Oxygenta Pharmaceutical had a promoter holding of 8.99% and a public holding of 91.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sp Ipropat Intellectual Property Solutions Private LimitedActive 10 years 5 monthsPadmaja Surapureddy is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 02 Sep 2022 | ₹5.00 Cr | Open |
Others Creation Date: 02 Sep 2022 | ₹10.00 Cr | Open |
Others Creation Date: 21 Dec 2020 | ₹6.70 Cr | Open |
How Many Employees Work at Oxygenta Pharmaceutical?
Oxygenta Pharmaceutical has a workforce of 98 employees as of Sep 11, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Oxygenta Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oxygenta Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
